logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S, Pujades M, Fontanet AL
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
BACKGROUND
In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.

METHODS
Cohort study of 2451 Cambodian and 2618 Kenyan adults who initiated antiretroviral therapy between 2001 and 2007. The prognostic value of weight gain at 3 months of antiretroviral therapy on 3-6 months mortality, and at 6 months on 6-12 months mortality, was investigated using Poisson regression.

RESULTS
Mortality rates [95% confidence interval (CI)] between 3 and 6 months of antiretroviral therapy were 9.9 (7.6-12.7) and 13.5 (11.0-16.7) per 100 person-years in Cambodia and Kenya, respectively. At 3 months, among patients with initial body mass index less than or equal to 18.5 kg/m (43% of the study population), mortality rate ratios (95% CI) were 6.3 (3.0-13.1) and 3.4 (1.4-8.3) for those with weight gain less than or equal to 5 and 5-10%, respectively, compared with those with weight gain of more than 10%. At 6 months, weight gain was also predictive of subsequent mortality: mortality rate ratio (95% CI) was 7.3 (4.0-13.3) for those with weight gain less than or equal to 5% compared with those with weight gain of more than 10%.

CONCLUSION
Weight gain at 3 months is strongly associated with survival. Poor compliance or undiagnosed opportunistic infections should be investigated in patients with initial body mass index less than or equal to 18.5 and achieving weight gain less than or equal to 10%.

Countries

Cambodia Kenya

Subject Area

HIV/AIDS

Languages

English
DOI
10.1097/QAD.0b013e32832913ee
Published Date
27 Apr 2009
PubMed ID
19287299
Journal
AIDS
Volume | Issue | Pages
Volume 23, Issue 7, Pages 853-861
Issue Date
2009-04-27
Dimensions Badge